After a complicated year full of challenges, learnings and changes in our personal and professional lives, it is time to turn the page, act boldly and focus ourselves on our objectives for FY22. It is part of our DNA to move with speed and decisiveness and compete to win! So, it is a pleasure for the global & regional team to provide you the tools necessary to continue gaining market share and access to more patients by demonstrating clinical & economic evidence in our technologies. We are very pleased to present the GLOBAL VALUE DOSSIER from TRI-STAPLE AND AUTOMATED STAPLING SYSTEMS. This is a document developed in partnership by the marketing and medical affairs teams addressing customer and employee’s needs.
This GVD is of great relevance for all of us, it has more than 130 articles that support the value proposition of Tri-Staple and Signia covering all major procedures served by Stapling business and brings together evidence of our technologies in one convenient package which includes:
Evolution of Medtronic stapling technology
Pre-clinical, benchtop and clinical studies
Healthcare economics on surgical stapling
Metanalysis and other data points from almost all the geographies
Please make sure you read and understand this document, this will give the necessary tools to engage conversations with our key stakeholders.
Sr. Marketing Manager SI LATAM